Onto Innovation
ONTO
304.40
-9.31
-2.97%
Onto Innovation
US · ONTO
#1120 by market cap
Listed 1970
304.40
-9.31
-2.97%
Live - 5344 symbols - heartbeat 120s ago
· 2026-10-08 06:27
Pre-market
296.01
-2.76%
After-hours
305.00
+0.20%
Overnight
297.93
-2.13%
- Market cap
- 14.94B
- P/E (TTM)i
- 114.01
- P/Bi
- 7.77
- EPSi
- 2.78
- Div yieldi
- 0.00%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on ONTO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 35.16, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.82% YoY
Margins
- Gross margin
- 49.72%
- Operating margin
- 15.06%
- Net margin
- 13.60%
Key ratios & quality
- Altman Z-Scorei
- 35.16
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 273.78M | 305.90M | 556.50M | 788.90M | 1.01B | 815.87M | 987.32M | 1.01B |
| Gross profit | 148.28M | 135.03M | 278.45M | 429.09M | 539.22M | 420.25M | 515.31M | 499.77M |
| Selling & admin expenses | 55.71M | 81.27M | 113.45M | 125.20M | 135.27M | 141.34M | 155.90M | 177.03M |
| Research & development | 39.95M | 48.36M | 84.58M | 96.12M | 111.95M | 104.44M | 113.86M | 131.98M |
| Operating profit | 51.08M | -5.04M | 26.68M | 156.41M | 236.71M | 119.65M | 196.11M | 151.35M |
| Pretax profit | 53.35M | -597.00K | 26.87M | 155.68M | 241.58M | 132.58M | 220.45M | 162.90M |
| Tax | 8.25M | -2.51M | -4.16M | 13.33M | 18.25M | 11.42M | 18.78M | 26.14M |
| Net profit | 45.10M | 1.91M | 31.03M | 142.35M | 223.33M | 121.16M | 201.67M | 136.76M |
| Basic EPS | 2 | 0 | 1 | 3 | 5 | 2 | 4 | 3 |
| Diluted EPS | 1.74 | 0.06 | 0.63 | 2.86 | 4.49 | 2.46 | 4.06 | 2.78 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 266.61M | 253.60M | 218.19M | 266.87M | 291.95M | 343.13M |
| Gross profit | 143.23M | 122.12M | 110.62M | 123.79M | 146.39M | 183.25M |
| Selling & admin expenses | 42.50M | 39.91M | 41.92M | 52.70M | 52.87M | 57.37M |
| Research & development | 28.03M | 35.29M | 32.49M | 36.16M | 35.10M | 38.88M |
| Operating profit | 64.26M | 38.47M | 27.76M | 20.86M | 38.72M | 67.31M |
| Pretax profit | 71.66M | 39.74M | 31.98M | 19.53M | 38.05M | 68.50M |
| Tax | 7.56M | 5.83M | 3.76M | 9.00M | 4.30M | 8.39M |
| Net profit | 64.10M | 33.91M | 28.22M | 10.53M | 33.75M | 60.10M |
| Basic EPS | 1 | 1 | 1 | 0 | 1 | 1 |
| Diluted EPS | 1.30 | 0.69 | 0.57 | 0.21 | 0.67 | 1.21 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 350.91M | 641.66M | 731.66M | 948.09M | 1.13B | 1.28B | 1.48B | 1.27B |
| Cash & ST investments | 175.07M | 320.24M | 373.72M | 511.34M | 547.78M | 697.81M | 852.33M | 639.62M |
| Inventory | 96.82M | 176.13M | 191.22M | 243.11M | 324.28M | 327.77M | 286.98M | 298.26M |
| Total assets | 418.04M | 1.45B | 1.47B | 1.65B | 1.79B | 1.91B | 2.12B | 2.37B |
| Total current liabilities | 44.99M | 85.74M | 120.09M | 154.53M | 160.56M | 147.73M | 170.09M | 218.95M |
| Short-term debt | -- | 4.91M | 4.47M | 3.97M | 5.68M | 5.49M | 5.42M | 6.22M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 56,152,000.00 | 184,554,000.00 | 203,426,000.00 | 223,758,000.00 | 198,437,000.00 | 173,177,000.00 | 191,209,000.00 | 267,094,000.00 |
| Total equity | 361.89M | 1.26B | 1.26B | 1.43B | 1.60B | 1.74B | 1.93B | 2.10B |
| Retained earnings | -6.77M | -4.86M | 26.16M | 168.51M | 362.76M | 482.36M | 664.55M | 743.79M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.47B | 1.49B | 1.54B | 1.27B | 1.32B | 2.64B |
| Cash & ST investments | 850.61M | 894.94M | 983.93M | 639.62M | 654.16M | 1.88B |
| Inventory | 292.66M | 270.22M | 259.37M | 298.26M | 316.03M | 379.24M |
| Total assets | 2.12B | 2.14B | 2.19B | 2.37B | 2.40B | 3.70B |
| Total current liabilities | 174.48M | 155.78M | 162.87M | 218.95M | 214.45M | 271.65M |
| Short-term debt | 5.95M | 5.25M | 5.63M | 6.22M | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | 1.47B |
| Total liabilities | 195,430,000.00 | 177,000,000.00 | 184,544,000.00 | 267,094,000.00 | 264,178,000.00 | 1,776,384,000.00 |
| Total equity | 1.92B | 1.96B | 2.00B | 2.10B | 2.13B | 1.92B |
| Retained earnings | 671.12M | 705.03M | 733.26M | 743.79M | 777.54M | 837.64M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 35.09M | 18.15M | 105.98M | 175.28M | 136.70M | 171.97M | 245.68M | 328.32M |
| Depreciation & amortization | 6.38M | 16.41M | 67.58M | 65.80M | 64.66M | 67.21M | 62.31M | 60.44M |
| Free cash flow | 27.55M | 11.34M | 102.16M | 163.24M | 118.30M | 149.40M | 213.77M | 299.80M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -21.07M | -744.00K | -52.00M | 0 | -65.26M | -3.20M | -25.07M | -75.02M |
| Ending cash balance | 112.39M | 130.67M | 136.72M | 169.60M | 175.87M | 233.51M | 212.95M | 346.12M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 91.98M | 57.94M | 83.40M | 95.00M | 26.32M | 61.51M |
| Depreciation & amortization | 12.84M | 14.29M | 13.38M | 19.93M | 25.48M | 25.53M |
| Free cash flow | 83.75M | 44.17M | 82.02M | 89.87M | 22.74M | 57.85M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -75.02M | 0 | 0 | 0 | 0 | -204.98M |
| Ending cash balance | 203.73M | 217.47M | 603.09M | 346.12M | 252.25M | 1.25B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.98 | 0.23 | 2.45 | 10.58 | 14.78 | 7.27 | 11.01 | 6.79 |
| ROA %i | 11.22 | 0.20 | 2.13 | 9.13 | 12.97 | 6.54 | 10.02 | 6.10 |
| ROIC %i | 12.98 | -0.09 | 2.25 | 10.35 | 14.28 | 6.08 | 9.25 | 5.29 |
| 5-year avg ROE %i | 8.31 | 8.70 | 7.85 | 7.35 | 8.20 | 7.06 | 9.22 | 10.09 |
| EBIT margin %i | 18.66 | -1.65 | 4.79 | 19.83 | 23.55 | 14.23 | 18.95 | 15.06 |
| FCF / sales %i | 10.06 | 3.71 | 18.36 | 20.69 | 11.77 | 18.31 | 21.65 | 29.82 |
| Current ratioi | 7.80 | 7.48 | 6.09 | 6.14 | 7.07 | 8.69 | 8.69 | 5.79 |
| Quick ratioi | 5.32 | 5.18 | 4.35 | 4.46 | 4.92 | 6.26 | 6.82 | 4.15 |
| Debt / assetsi | 0.00 | 1.72 | 1.43 | 1.07 | 1.23 | 1.02 | 0.72 | 0.74 |
| LT debt / equityi | -- | 1.58 | 1.30 | 0.96 | 1.02 | 0.81 | 0.51 | 0.54 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 7.29 | 9.53 | 29.69 | 42.30 | 48.67 | 13.60 | 7.77 | 0.00 |
| Net income CAGR (3Y) %i | 35.93 | -62.75 | -1.95 | 46.69 | 389.00 | 57.48 | 12.31 | -15.08 |
| FCF CAGR (3Y) %i | -0.24 | -35.43 | 24.48 | 80.95 | 118.48 | 13.51 | 9.41 | 36.34 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.83 | 10.53 | 8.96 | 6.79 | 5.25 | 6.82 |
| ROA %i | 10.76 | 9.64 | 8.22 | 6.10 | 4.72 | 4.54 |
| ROIC %i | 10.01 | 8.79 | 7.24 | 5.29 | 4.00 | 4.09 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 20.24 | 19.05 | 16.95 | 15.06 | 12.21 | 13.81 |
| FCF / sales %i | 24.13 | 23.01 | 26.07 | 29.82 | 23.17 | 22.54 |
| Current ratioi | 8.42 | 9.59 | 9.49 | 5.79 | 6.15 | 9.73 |
| Quick ratioi | 6.55 | 7.58 | 7.64 | 4.15 | 4.48 | 8.17 |
| Debt / assetsi | 0.69 | 0.63 | 0.64 | 0.74 | -- | 39.79 |
| LT debt / equityi | 0.45 | 0.42 | 0.42 | 0.54 | -- | 76.55 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Design, development, manufacture and support of high-performance control metrology, defect100.00%
Quote time 2026-10-08 06:27:41 · For reference only, not investment advice and not tailored to your situation.